Radiopharmaceutical Chemistry

Radiochemistry and Radiopharmaceutical Chemistry for Medicine

Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy

The fields of molecular biology, immunology and genetics have generated many important developments that advance the understanding of the induction and progression of oncological, cardiological and neurological diseases as well as the identification of disease-associated molecules and drugs that specifically target diseased cells during therapy. These insights have triggered the development of ...

Shades of grey: radiopharmaceutical chemistry in the 1990s and beyond.

Science, like the universe itself, is ever expanding. The fields of biochemistry, physiology and pharmacology are rapidly growing, and radiopharmaceutical chemistry is no exception. In a recent Editorial Dr William C. Eckelman briefly reviewed the current status of radiopharmaceutical development (Eckelman, 1991). The ballots are out and returns are mixed. Radiopharmaceutical chemists have made...

Ga Radiopharmaceutical Preparations

The renaissance of Ga radiopharmacy has led to great advances in automation technology. The availability of a highly efficient, reliable, long-lived Ge/Ga generator system along with a well-established coordination chemistry based on bifunctional chelating agents have been the bases of this development in Ga radiopharmacy. Syntheses of Ga peptides were originally performed by manual or semiauto...

Radiopharmaceutical drug interactions.

There has been considerable under-reporting of drug and radiopharmaceutical interactions, security and adverse reactions. The increasing use of radiopharmaceuticals has come to the attention of nuclear medicine staff and regulatory bodies. The aim is to provide reference for adverse reactions which could help all nuclear medicine staff in their daily routine. Reporting adverse events, including...